Washington Trust’s Integra LifeSciences IART Stock Holding History

Washington Trust’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-35	Closed	-$1.34K	–	888
2023 Q3	$1.34K	Hold	35	–	–	﹤0.01%	812
2023 Q2	$1.44K	Sell	35 -1	-3%	-$48	﹤0.01%	825
2023 Q1	$2.07K	Buy	36 +3	+9%	+$169	﹤0.01%	807
2022 Q4	$1.85K	Buy	33 +6	+22%	+$305	﹤0.01%	822
2022 Q3	$1K	Hold	27	–	–	﹤0.01%	868
2022 Q2	$1K	Buy	27 +2	+8%	+$120	﹤0.01%	872
2022 Q1	$2K	Hold	25	–	–	﹤0.01%	828
2021 Q4	$2K	Buy	25 +1	+4%	+$68	﹤0.01%	834
2021 Q3	$2K	Buy	+24	New	+$1.7K	﹤0.01%	959

Other funds holding IART

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Washington Trust's IART Position: Q4 2023 in Review

Washington Trust sold out of Integra LifeSciences (IART) in Q4 2023, closing a stake of 35 shares — an estimated $1.34K sold.

Washington Trust first reported a position in IART in Q3 2021 and held it in 9 quarters. The position peaked at $2.07K in Q1 2023. 284 funds tracked by Wall St. Rank hold IART as of Q4 2023.

Washington Trust reported no remaining Integra LifeSciences position as of Q4 2023 after selling out during the quarter.
Washington Trust sold 35 Integra LifeSciences shares in Q4 2023, an estimated $1.34K.
Washington Trust first reported a position in Integra LifeSciences in Q3 2021 and held it in 9 quarters.
Washington Trust's Integra LifeSciences position peaked at $2.07K in Q1 2023.
284 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2023.

Based on Washington Trust's 13F filing for Q4 2023, filed 18 Jan 2024.